Biosimulation Market Size, Share, and Outlook, H2-2025 Report- By Product (Software, Services), By Application (Drug Development, Drug Discovery, Others), By Delivery Model (Subscription Models, Ownership Models), By End-User (Pharmaceutical & Biotechnolo
Description
Biosimulation Market Outlook
The global Biosimulation Market Size is valued at $4.5 Billion in 2025 and is forecast to reach $13 Billion in 2032 at a CAGR of 16.3%.
The Biosimulation Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Biosimulation Market segments across 22 countries from 2021 to 2032. Key segments covered include By Product (Software, Services), By Application (Drug Development, Drug Discovery, Others), By Delivery Model (Subscription Models, Ownership Models), By End-User (Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities, Academic Research Institutions), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Biosimulation Market Insights, 2025
The biosimulation market is evolving with the integration of computational biology, systems pharmacology, and AI to model complex biological processes and predict drug responses. Recent innovations include multi-scale modeling, virtual clinical trials, and organ-on-chip simulations that reduce drug development timelines and costs. Regulatory agencies increasingly recognize biosimulation data for decision-making, encouraging broader adoption. Pharmaceutical companies use biosimulation to optimize dosing, identify biomarkers, and de-risk clinical development. Cloud-based platforms and enhanced computational power enable collaborative, real-time modeling. Expansion into personalized medicine and precision therapeutics drives demand. The market also faces challenges in data standardization and model validation, which are being addressed through industry consortia and standards.
Five Trends Shaping the Global Biosimulation Market in 2025 and Beyond
The global Biosimulation Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Biosimulation Industry?
The Biosimulation Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Biosimulation Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Biosimulation Market Segment Insights
The Biosimulation Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Product (Software, Services), By Application (Drug Development, Drug Discovery, Others), By Delivery Model (Subscription Models, Ownership Models), By End-User (Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities, Academic Research Institutions). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Biosimulation Industry Value Chain
The chapter identifies potential companies and their operations across the global Biosimulation Industry ecosystem. It assists decision-makers in evaluating global Biosimulation Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Biosimulation Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Biosimulation Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Biosimulation Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Biosimulation Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Biosimulation Market.
Europe Biosimulation Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Biosimulation Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Biosimulation Industry competitiveness. The report analyses the key Biosimulation Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Biosimulation Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Biosimulation Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Biosimulation Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Biosimulation Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Biosimulation Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Biosimulation Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Advanced Chemistry Development Inc, BioSimulation Consulting Inc, Certara LP, Chemical Computing Group ULC, Dassault Systèmes SE, Genedata AG, Immunetrics Inc, Instem Group plc, Physiomics Plc, PPD Inc, Rosa & Co. LLC, Schrodinger Inc, Simulation Plus, Yokogawa Insilico Biotechnology GmbH. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Biosimulation Market Scope
Leading Segments
By Product
Software
ServicesIn-house Services Contract Services
By Application
Drug Development
Drug Discovery
Others
By Delivery Model
Subscription Models
Ownership Models
By End-User
Pharmaceutical & Biotechnology Companies
CROs
Regulatory Authorities
Academic Research Institutions
Leading Companies
Advanced Chemistry Development Inc
BioSimulation Consulting Inc
Certara LP
Chemical Computing Group ULC
Dassault Systèmes SE
Genedata AG
Immunetrics Inc
Instem Group plc
Physiomics Plc
PPD Inc
Rosa & Co. LLC
Schrodinger Inc
Simulation Plus
Yokogawa Insilico Biotechnology GmbH
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report Make informed decisions with 12-year forecasts across 22 countries and multiple market segments. Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry. Gain insights into the competitive landscape, including company profiles, financials, and strategic moves. Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations. Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade. Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions. Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
The global Biosimulation Market Size is valued at $4.5 Billion in 2025 and is forecast to reach $13 Billion in 2032 at a CAGR of 16.3%.
The Biosimulation Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Biosimulation Market segments across 22 countries from 2021 to 2032. Key segments covered include By Product (Software, Services), By Application (Drug Development, Drug Discovery, Others), By Delivery Model (Subscription Models, Ownership Models), By End-User (Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities, Academic Research Institutions), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Biosimulation Market Insights, 2025
The biosimulation market is evolving with the integration of computational biology, systems pharmacology, and AI to model complex biological processes and predict drug responses. Recent innovations include multi-scale modeling, virtual clinical trials, and organ-on-chip simulations that reduce drug development timelines and costs. Regulatory agencies increasingly recognize biosimulation data for decision-making, encouraging broader adoption. Pharmaceutical companies use biosimulation to optimize dosing, identify biomarkers, and de-risk clinical development. Cloud-based platforms and enhanced computational power enable collaborative, real-time modeling. Expansion into personalized medicine and precision therapeutics drives demand. The market also faces challenges in data standardization and model validation, which are being addressed through industry consortia and standards.
Five Trends Shaping the Global Biosimulation Market in 2025 and Beyond
The global Biosimulation Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Biosimulation Industry?
The Biosimulation Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Biosimulation Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Biosimulation Market Segment Insights
The Biosimulation Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Product (Software, Services), By Application (Drug Development, Drug Discovery, Others), By Delivery Model (Subscription Models, Ownership Models), By End-User (Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities, Academic Research Institutions). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Biosimulation Industry Value Chain
The chapter identifies potential companies and their operations across the global Biosimulation Industry ecosystem. It assists decision-makers in evaluating global Biosimulation Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Biosimulation Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Biosimulation Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Biosimulation Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Biosimulation Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Biosimulation Market.
Europe Biosimulation Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Biosimulation Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Biosimulation Industry competitiveness. The report analyses the key Biosimulation Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Biosimulation Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Biosimulation Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Biosimulation Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Biosimulation Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Biosimulation Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Biosimulation Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Advanced Chemistry Development Inc, BioSimulation Consulting Inc, Certara LP, Chemical Computing Group ULC, Dassault Systèmes SE, Genedata AG, Immunetrics Inc, Instem Group plc, Physiomics Plc, PPD Inc, Rosa & Co. LLC, Schrodinger Inc, Simulation Plus, Yokogawa Insilico Biotechnology GmbH. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Biosimulation Market Scope
Leading Segments
By Product
Software
Services
By Application
Drug Development
Drug Discovery
Others
By Delivery Model
Subscription Models
Ownership Models
By End-User
Pharmaceutical & Biotechnology Companies
CROs
Regulatory Authorities
Academic Research Institutions
Leading Companies
Advanced Chemistry Development Inc
BioSimulation Consulting Inc
Certara LP
Chemical Computing Group ULC
Dassault Systèmes SE
Genedata AG
Immunetrics Inc
Instem Group plc
Physiomics Plc
PPD Inc
Rosa & Co. LLC
Schrodinger Inc
Simulation Plus
Yokogawa Insilico Biotechnology GmbH
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report
Table of Contents
189 Pages
- 1. Table of Contents
- List of Figures and Tables
- 2. Executive Summary
- 2.1 Key Highlights
- 2.1.1 Biosimulation Market Size Outlook, 2018-2024 and 2025-2032
- 2.1.2 Largest Biosimulation Market Types and Applications
- 2.1.3 Fastest Growing Segments
- 2.1.4 Potential Markets
- 2.1.5 Market Concentration
- 2.2 Market Scope and Segmentation
- 2.2.1 Market Scope- Segments
- 2.2.2 Market Scope- Countries
- 2.2.3 Macroeconomic and Demographic Outlook
- 2.2.4 Abbreviations
- 2.2.5 Units and Currency Conversions
- 3. Research Methodology
- 3.1 Primary Research Surveys
- 3.2 Secondary Data Sources
- 3.3 Data Triangulation
- 3.4 Forecast Methodology
- 3.5 Assumptions and Limitations
- 4. Introduction to Global Biosimulation Market in 2025
- 4.1 Industry Panorama
- 4.2 Leading Companies Profiled in the Study
- 4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
- 4.4 Market Dynamics
- 4.4.1 Market Dynamics- Trends and Drivers
- 4.4.2 Market Dynamics- Opportunities and Challenges
- 4.5 Regional Analysis
- 4.6 Porter’s Five Force Analysis
- 4.6.1 Intensity of Competitive Rivalry
- 4.6.2 Threat of New Entrants
- 4.6.3 Threat of Substitutes
- 4.6.4 Bargaining Power of Buyers
- 4.6.5 Bargaining Power of Suppliers
- 4.7 Biosimulation Market Industry Value Chain Analysis
- 4.7.1 Stage of Value Chain
- 4.7.2 Key Activities of Companies
- 4.7.3 Companies Included in Each Stage
- 4.7.4 Key Insights
- 5. Biosimulation Market Outlook to 2032
- 5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
- 5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
- 5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
- By Product
- Software
- Services
- -In-house Services
- -Contract Services
- By Application
- Drug Development
- Drug Discovery
- Others
- By Delivery Model
- Subscription Models
- Ownership Models
- By End-User
- Pharmaceutical & Biotechnology Companies
- CROs
- Regulatory Authorities
- Academic Research Institutions
- 6. Global Biosimulation Market Outlook across Growth Scenarios
- 6.1 Low Growth Scenario
- 6.2 Base/Reference Case
- 6.3 High Growth Scenario
- 6. North America Biosimulation Market Size Outlook
- 6.1 Key Market Statistics, 2024
- 6.2 North America Biosimulation Market Trends and Growth Opportunities
- 6.2.1 North America Biosimulation Market Outlook by Type
- 6.2.2 North America Biosimulation Market Outlook by Application
- 6.3 North America Biosimulation Market Outlook by Country
- 6.3.1 The US Biosimulation Market Outlook, 2021- 2032
- 6.3.2 Canada Biosimulation Market Outlook, 2021- 2032
- 6.3.3 Mexico Biosimulation Market Outlook, 2021- 2032
- 7. Europe Biosimulation Market Size Outlook
- 7.1 Key Market Statistics, 2024
- 7.2 Europe Biosimulation Market Trends and Growth Opportunities
- 7.2.1 Europe Biosimulation Market Outlook by Type
- 7.2.2 Europe Biosimulation Market Outlook by Application
- 7.3 Europe Biosimulation Market Outlook by Country
- 7.3.2 Germany Biosimulation Market Outlook, 2021- 2032
- 7.3.3 France Biosimulation Market Outlook, 2021- 2032
- 7.3.4 The UK Biosimulation Market Outlook, 2021- 2032
- 7.3.5 Spain Biosimulation Market Outlook, 2021- 2032
- 7.3.6 Italy Biosimulation Market Outlook, 2021- 2032
- 7.3.7 Russia Biosimulation Market Outlook, 2021- 2032
- 7.3.8 Rest of Europe Biosimulation Market Outlook, 2021- 2032
- 8. Asia Pacific Biosimulation Market Size Outlook
- 8.1 Key Market Statistics, 2024
- 8.2 Asia Pacific Biosimulation Market Trends and Growth Opportunities
- 8.2.1 Asia Pacific Biosimulation Market Outlook by Type
- 8.2.2 Asia Pacific Biosimulation Market Outlook by Application
- 8.3 Asia Pacific Biosimulation Market Outlook by Country
- 8.3.1 China Biosimulation Market Outlook, 2021- 2032
- 8.3.2 India Biosimulation Market Outlook, 2021- 2032
- 8.3.3 Japan Biosimulation Market Outlook, 2021- 2032
- 8.3.4 South Korea Biosimulation Market Outlook, 2021- 2032
- 8.3.5 Australia Biosimulation Market Outlook, 2021- 2032
- 8.3.6 South East Asia Biosimulation Market Outlook, 2021- 2032
- 8.3.7 Rest of Asia Pacific Biosimulation Market Outlook, 2021- 2032
- 9. South America Biosimulation Market Size Outlook
- 9.1 Key Market Statistics, 2024
- 9.2 South America Biosimulation Market Trends and Growth Opportunities
- 9.2.1 South America Biosimulation Market Outlook by Type
- 9.2.2 South America Biosimulation Market Outlook by Application
- 9.3 South America Biosimulation Market Outlook by Country
- 9.3.1 Brazil Biosimulation Market Outlook, 2021- 2032
- 9.3.2 Argentina Biosimulation Market Outlook, 2021- 2032
- 9.3.3 Rest of South and Central America Biosimulation Market Outlook, 2021- 2032
- 10. Middle East and Africa Biosimulation Market Size Outlook
- 10.1 Key Market Statistics, 2024
- 10.2 Middle East and Africa Biosimulation Market Trends and Growth Opportunities
- 10.2.1 Middle East and Africa Biosimulation Market Outlook by Type
- 10.2.2 Middle East and Africa Biosimulation Market Outlook by Application
- 10.3 Middle East and Africa Biosimulation Market Outlook by Country
- 10.3.1 Saudi Arabia Biosimulation Market Outlook, 2021- 2032
- 10.3.2 The UAE Biosimulation Market Outlook, 2021- 2032
- 10.3.3 Rest of Middle East Biosimulation Market Outlook, 2021- 2032
- 10.3.4 South Africa Biosimulation Market Outlook, 2021- 2032
- 10.3.5 Egypt Biosimulation Market Outlook, 2021- 2032
- 10.3.6 Rest of Africa Biosimulation Market Outlook, 2021- 2032
- 11. Company Profiles
- 11.1 Leading 10 Companies
- Advanced Chemistry Development Inc
- BioSimulation Consulting Inc
- Certara LP
- Chemical Computing Group ULC
- Dassault Systèmes SE
- Genedata AG
- Immunetrics Inc
- Instem Group plc
- Physiomics Plc
- PPD Inc
- Rosa & Co. LLC
- Schrodinger Inc
- Simulation Plus
- Yokogawa Insilico Biotechnology GmbH
- 11.2 Overview
- 11.3 Products and Services
- 11.4 SWOT Profile
- 12. Appendix
- 12.1 Subscription Options
- 12.2 Customization Options
- 12.3 Publisher Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
